ZYLOTS analysis team have also rated this as a buy with a target ranging somewhere from 13c to $1.30 dependent on rampingbelieve whoever you like....DYOR
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025